Article
B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infection
2019-02-06
Abstract excerpt
Effective vaccines inducing lifelong protection against many important infections such as respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), influenza and Epstein-Barr virus (EBV) are not yet available despite decades of research. As an alternative to a protective vaccine we developed a genetic engineering strategy in which CRISPR/Cas9 was utilized to replace endogenously-encoded antibodies wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 91db7e68-0557-5985-bfd9-31a3f2bfc438
- DOI
- 10.1101/541979
